OncoImmune has a robust pipeline, deep biology insights into CD24–Siglec and CTLA-4 signaling, and a very flexible approach to partnering. It is looking for strategic partners and/or investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback